Replies to post #230901 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

No Kabunashi.

It is called contingency planning. You build out the three likely scenarios going forward beginning Feb 2017. Why Feb 2017? Because as an investor, I was told in a PR that is when they started. If I am wrong about that, please show me how am I wrong.

Then, you look for the overlap in analysis that does not change regardless of which of your three scenarios plays out. You work on that piece and your most likely scenario first. Then, you go to number two and from there you get the point. Or at least, that’s how I have seen it down through 8 launches and two failed phase threes. If they did not do this it, it is inexcusable. If they needed to wait on step two for more cash, I understand. What was the 5.4M loan for, how about Biggers cash? How long ago did The Hauwei deal close?

I am not whining. I am pointing out that I am not pleased with this progress and that it is behind schedule for even a very small biotech like say Array or Incyte, or even fracking Dendreon who faced the EXACT SAME HURDLES and MANIPULATION.

So go fly a kite Kab because I do not want to listen to your hot air.